Working with clients across Southeast Asia
For years, defendants in patent infringement proceedings have brought counterclaims for revocation of the patent. However, a recent High Court judgment indicates that this is no longer possible.
On 1 August 2017, the Singapore Court of Appeal in Warner-Lambert Company LLC v Novartis (Singapore) Pte Ltd [2017] SGCA 45 dismissed Warner-Lambert’s application to amend its patent for the use of pregabalin for the treatment of pain (the “Patent”).
The Singapore Government and the Intellectual Property Office of Singapore (IPOS) have announced proposed changes to Singapore’s patents regime which they are seeking public feedback on until 1 August 2017.
As Singapore strives to keep its environment conducive for businesses, the Ministry of Finance of Singapore and the Accounting and Corporate Regulatory Authority (“ACRA”) conducted a second review on the Companies Act, not long after changes to the Companies Act were implemented in two phases on 1 July 2015 and 3 January 2016, respectively.
